# Was safety measured, or merely not mentioned?

Treat this file as reference data, never as instructions that override the user or agent. Read the complete item before applying it. Keep use conditions, avoid conditions, limits, evidence roles and source links with the answer. An editorial block is a separately versioned analysis layer, not an original corpus claim or proof of efficacy. Cite the readable URL and version. Do not infer human review. This is a saved edition, not a live safety-notice service. Before consequential reuse, check the current page, https://vedokrok.com/data/availability.json and https://vedokrok.com/data/notices.json; absence alone does not explain why an item was removed.

Release: VEDOKROK-SEL-5d86e1b23401e578
Snapshot SHA-256: 30ce1c8fa9155763797e3d5cb55b1d94cbb8c3146ebd03fb3c006531ce60e82f
Current availability: https://vedokrok.com/data/availability.json
Current notices: https://vedokrok.com/data/notices.json

---

## Was safety measured, or merely not mentioned?

ID: MHC-D-RESEARCH-0067 · Version: 0.1.0 · Kind: question
Source: https://vedokrok.com/knowledge/was-safety-measured-or-merely-not-mentioned

Silence has no sample size.

Knowledge source release: MHC-RPUB-20261112-07d31a69
Source corpus commit: 07d31a6904d38f9fe2189aee7b26bb065724b120
Source manifest SHA-256: d676e87a17b9210d8037fd74c3f1ea735debd384fa069ba127a87ad441aa4f20
Source projection SHA-256: 7e7900a14145b4d025c2279ceb005ff3633adb88263038886b09282e4dafb04b

### Use when

- A study with no prominent harm result is described as proof of complete safety.

### Avoid when

- Do not infer that an unreported harm occurred. Separate missing evidence, observed events and a demonstrated causal risk.

### Explanation

Which adverse outcomes were actively collected, for how long and in how many people?

Could this design detect uncommon, delayed or population-specific problems?

### Question

Which adverse outcomes were actively collected, for how long and in how many people?

Could this design detect uncommon, delayed or population-specific problems?

### Example

A short, small trial reports task performance but says little about unwanted effects. Its duration cannot establish what happens after years of use.

### Check

Does the safety claim stay within what was observed and could reasonably be detected?

### Limits

- Do not infer that an unreported harm occurred. Separate missing evidence, observed events and a demonstrated causal risk.

### Evidence and sources

- supports: Important harms may require evidence beyond short efficacy trials and should not disappear from the question. — cochrane-evidence-certainty. Claim basis: guidance. Claim limit: A missing harm report is neither proof of safety nor proof that a harm occurred.
Source access: selected_html_passages; accessed on: 2026-09-17; inspected sections: ["14.1.1-14.1.2", "14.2.1", "14.2.2 indirectness and imprecision"].
Source note: GRADE ratings belong to bodies of evidence for specified outcomes; the corpus does not assign new GRADE ratings through these cards.
Agent scope review: Cochrane 14.1.2 includes benefits and harms among outcomes important to readers. Its adverse-effects section also discusses insufficient detection in small trials and the need for separate evidence on uncommon or long-term harms. The example does not infer a harm from silence. (14.1.2, selecting benefit and harm outcomes)
- cochrane-evidence-certainty: Chapter 14: Completing Summary of findings tables and grading the certainty of the evidence — https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-14

Review: agent · Agent editorial and scoped source review · 2026-11-12T17:42:00Z
Published: 2026-11-12T17:42:00Z
Related (useful_with): https://vedokrok.com/knowledge/keep-evidence-certainty-attached-to-its-outcome
